Construction and Validation of Two Novel Nomograms for Predicting the Overall Survival and Cancer-Specific Survival of NSCLC Patients with Bone Metastasis

References

• Klebe S, Leigh J, Henderson DW, Nurminen M. Asbestos, smoking and lung cancer: an update. Int J Environ Res Public Health. 2019;17(1):258. doi:10.3390/ijerph17010258
   PubMed Web of Science ®Google Scholar
• Hong S, Mok Y, Jeon C, Jee SH, Samet JM. Tuberculosis, smoking and risk for lung cancer incidence and mortality. Int J Cancer. 2016;139(11):2447–2455. doi:10.1002/ijc.30384
   PubMed Web of Science ®Google Scholar
• Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7. doi:10.1111/1759-7714.12916
   PubMed Web of Science ®Google Scholar
• Ferlay J, Ervik M, Lam F, et al. Global cancer observatory: cancer today. Lyon, France: International Agency for Research on Cancer; 2020 [cited September 28, 2021]. Available from: https://gco.iarc.fr/today. Accessed November 24, 2021.
   Google Scholar
• Hwang JK, Page BJ, Flynn D, et al. Validation of the Eighth Edition TNM lung cancer staging system. J Thorac Oncol. 2020;15(4):649–654. doi:10.1016/j.jtho.2019.11.030
   PubMed Web of Science ®Google Scholar
• Shirasawa M, Fukui T, Kusuhara S, et al. Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer. Cancer Manag Res. 2018;10:6039–6047. doi:10.2147/CMAR.S181789
   PubMed Web of Science ®Google Scholar
• Fei H, Chen S, Xu C. Interactive verification analysis of multiple sequencing data for identifying potential biomarker of lung adenocarcinoma. Biomed Res Int. 2020;2020:8931419. doi:10.1155/2020/8931419
   PubMed Web of Science ®Google Scholar
• Jing X, Li F, Meng X, Liu Z, Yu J, Liu B. Ovarian metastasis from lung adenocarcinoma with ALK-positive rearrangement detected by next generation sequencing: a case report and literatures review. Cancer Biol Ther. 2017;18(5):279–284. doi:10.1080/15384047.2017.1310344
   PubMed Web of Science ®Google Scholar
• Semrau S, Zettl H, Hildebrandt G, Klautke G, Fietkau R. Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy. Strahlenther Onkol. 2014;190(12):1125–1132. doi:10.1007/s00066-014-0710-5
   PubMed Web of Science ®Google Scholar
• Katsumata S, Aokage K, Ishii G, et al. Prognostic impact of the number of metastatic lymph nodes on the Eighth Edition of the TNM classification of NSCLC. J Thorac Oncol. 2019;14(8):1408–1418. doi:10.1016/j.jtho.2019.04.016
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou F, Liu Z, et al. Predictive and prognostic significance of M descriptors of the 8th TNM classification for advanced NSCLC patients treated with immune checkpoint inhibitors. Transl Lung Cancer Res. 2020;9(4):1053–1066. doi:10.21037/tlcr-19-396
   PubMed Web of Science ®Google Scholar
• Zheng XQ, Huang JF, Lin JL, et al. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res. 2019;8(4):367–379. doi:10.21037/tlcr.2019.08.16
   PubMed Web of Science ®Google Scholar
• Mulshine JL, Sullivan DC. Clinical practice lung cancer screening. N Engl J Med. 2005;352:2714–2720. doi:10.1056/NEJMcp042630
   PubMed Web of Science ®Google Scholar
• Torok JA, Gu L, Tandberg DJ, et al. Patterns of distant metastases after surgical management of non-small-cell lung cancer. Clin Lung Cancer. 2017;18(1):e57–e70. doi:10.1016/j.cllc.2016.06.011
   PubMed Web of Science ®Google Scholar
• LeVasseur N, Clemons M, Hutton B, Shorr R, Jacobs C. Bone-targeted therapy use in patients with bone metastases from lung cancer: a systematic review of randomized controlled trials. Cancer Treat Rev. 2016;50:183–193. doi:10.1016/j.ctrv.2016.09.013
   PubMed Web of Science ®Google Scholar
• Costa L, Badia X, Chow E, Lipton A, Wardley A. Impact of skeletal complications on patients’ quality of life, mobility, and functional Independence. Support Care Cancer. 2008;16(8):879–889. doi:10.1007/s00520-008-0418-0
   PubMed Web of Science ®Google Scholar
• Wood DE, Kazerooni EA, Baum SL, et al. Lung cancer screening, Version 3.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(4):412–441. doi:10.6004/jnccn.2018.0020
   PubMed Web of Science ®Google Scholar
• Yap WK, Shih MC, Kuo C, et al. Development and validation of a nomogram for assessing survival in patients with metastatic lung cancer referred for radiotherapy for bone metastases. JAMA Netw Open. 2018;1(6):e183242. doi:10.1001/jamanetworkopen.2018.3242
   PubMed Web of Science ®Google Scholar
• Song Q, Shang J, Zhang C, Zhang L, Wu X. Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients. J Cancer Res Clin Oncol. 2019;145(3):737–746. doi:10.1007/s00432-018-02826-7
   PubMed Web of Science ®Google Scholar
• Liu S, Sun W, Yang S, et al. Deep learning radiomic nomogram to predict recurrence in soft tissue sarcoma: a multi-institutional study. Eur Radiol. 2021. doi:10.1007/s00330-021-08221-0
   Web of Science ®Google Scholar
• Li Y, Chen Y, Zhao R, et al. Development and validation of a nomogram based on pretreatment dynamic contrast-enhanced MRI for the prediction of pathologic response after neoadjuvant chemotherapy for triple-negative breast cancer. Eur Radiol. 2021. doi:10.1007/s00330-021-08291-0
   Web of Science ®Google Scholar
• Kuchuk M, Addison CL, Clemons M, Kuchuk I, Wheatley-Price P. Incidence and consequences of bone metastases in lung cancer patients. J Bone Oncol. 2013;2(1):22–29. doi:10.1016/j.jbo.2012.12.004
   PubMed Web of Science ®Google Scholar
• Mallet R, Decazes P, Modzelewski R, et al. Prognostic value of low skeletal muscle mass in patient treated by exclusive curative radiochemotherapy for a NSCLC. Sci Rep. 2021;11(1):10628. doi:10.1038/s41598-021-90187-6
   PubMed Web of Science ®Google Scholar
• Wu XT, Zhou JW, Pan LC, Ge T. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer. J Int Med Res. 2020;48(5):300060520925644. doi:10.1177/0300060520925644
   PubMed Web of Science ®Google Scholar
• Shan Q, Li Z, Lin J, et al. Tumor primary location may affect metastasis pattern for patients with Stage IV NSCLC: a Population-Based Study. J Oncol. 2020;2020:4784701. doi:10.1155/2020/4784701
   PubMed Web of Science ®Google Scholar
• Jusue-Torres I, Hulbert A, Zakaria J, et al. Socioeconomic disparities in non-small cell lung cancer with brain metastases at presentation: a Population-Based Study. World Neurosurg. 2021;154:e236–e244. doi:10.1016/j.wneu.2021.07.024
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang Y, Sun X, et al. The prognostic value of multiorgan metastases in patients with non-small cell lung cancer and its variants: a SEER-based study. J Cancer Res Clin Oncol. 2018;144(9):1835–1842. doi:10.1007/s00432-018-2702-9
   PubMed Web of Science ®Google Scholar